Illumina Urinary Pathogen Identification (ID)/Antimicrobial Resistance (AMR) Enrichment Kit (UPIP), (1) Respiratory Pathogen ID/AMR Enrichment Kit Set A,

SOL #: HT941026N0054Award NoticeSole Source

Overview

Buyer

DEPT OF DEFENSE
Defense Health Agency (Dha)
DEFENSE HEALTH AGENCY HCD WEST
CAMP PENDLETON, CA, 92055, United States

Place of Performance

Tripler Army Medical Center, HI

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

In Vitro Diagnostic Substances, Reagents, Test Kits And Sets (6550)

Set Aside

No set aside specified

Timeline

1
Posted
May 4, 2026
2
Last Updated
May 30, 2026

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Defense Health Agency (DHA) has awarded a Firm Fixed-Price contract, HT941026PE068, for Illumina Urinary Pathogen Identification (ID)/Antimicrobial Resistance (AMR) Enrichment Kits and other sequencing supplies. This award, valued at $273,351.68, supports the Department of Clinical Investigation at Tripler Army Medical Center, HI. The contract was awarded on May 30, 2026.

Scope of Work

The contract covers the supply of various Illumina sequencing and bacterial analysis kits, reagents, and related supplies. Key items include:

  • Urinary Pathogen ID/AMR Enrichment Kits
  • NextSeq and MiSeq Reagent Kits
  • Illumina DNA Prep and DNA/RNA UD Indexes
  • Respiratory Virus Enrichment Kits
  • PhiX Control v3 No substitutes or alternatives are accepted, and items must be delivered before expiration and without temperature excursions.

Contract & Timeline

  • Contract Number: HT941026PE068
  • Type: Firm Fixed Price
  • Award Date: May 30, 2026
  • Total Award Amount: $273,351.68
  • Delivery: On or before September 30, 2026, to Tripler Army Medical Center, HI.

Set-Aside & Justification

This acquisition was awarded as UNRESTRICTED. However, a prior Notice of Intent indicated the agency's intent to award on a sole source basis to Illumina, Inc. The justification cited was that Illumina is the only vendor manufacturing the specific sequencing supplies compatible with the Government-owned MiSeq System at Tripler Army Medical Center. The NAICS code is 541714 (Research and Development in Biotechnology) with a 1,000-employee size standard.

Additional Notes

Payment will be processed via Wide Area WorkFlow (WAWF). For inquiries, the secondary contact is CHA-ON Gordon at cha-on.p.gordon2.civ@health.mil or 726-203-0109.

People

Points of Contact

Unnamed ContactPRIMARY

Files

Files

Download
Download

Versions

Version 2Viewing
Award Notice
Posted: May 30, 2026
Version 1
Special Notice
Posted: May 4, 2026
View
Illumina Urinary Pathogen Identification (ID)/Antimicrobial Resistance (AMR) Enrichment Kit (UPIP), (1) Respiratory Pathogen ID/AMR Enrichment Kit Set A, | GovScope